Lv1
30 积分 2024-08-19 加入
Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy
1个月前
已完结
Co-expression pattern of CD8, CXCR5 and CXCL13 in tumor microenvironment predicts favorable efficacy of immunotherapy in lung adenocarcinoma
1个月前
已完结
Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer
1个月前
已完结
Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified
1个月前
已完结
Online Adaptive Proton Therapy Facilitated by Artificial Intelligence-Based Autosegmentation in Pencil Beam Scanning Proton Therapy
1个月前
已完结
Deep Learning Blood Dosimetry Predicts Severe Lymphopenia and Survival After Craniospinal Irradiation
1个月前
已完结
CXCL13 shapes tertiary lymphoid structures and promotes response to immunotherapy in bladder cancer
2个月前
已完结
B cells are major players in cancer immunity
2个月前
已完结
Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer
2个月前
已完结
Antigen-presenting CAFs orchestrate immunosuppressive niches via CXCL13-mediated immune cell infiltration dysregulation and prognostic stratification in triple-negative breast cancer
2个月前
已完结
皖公网安备34019202002308
